Analysis

/Analysis

Q4 & Annual 2017 Share Price Performance – Part 3

By | January 25th, 2018|Analysis, Blog, Capital Markets|

            Tier 2 Canadian Healthcare [...]

Q4 & Annual 2017 Share Price Performance – Part 2

By | January 22nd, 2018|Analysis, Blog, Capital Markets|

              Tier 1 Canadian [...]

Q4 Share Price Performance in 2017 – Part 1

By | January 17th, 2018|Analysis, Blog, Capital Markets|

          Q4 and 12-Month 2017 Share [...]

Q3 Share Price Performance in 2017 – Part 3

By | November 8th, 2017|Analysis, Blog, Capital Markets|

  Tier 2 Canadian Healthcare Companies: Moderately Negative with Usual [...]

Q3 Share Price Performance in 2017 – Part 2

By | November 8th, 2017|Analysis, Blog, Capital Markets|

  Tier 1 Canadian Healthcare Companies: Mixed and Volatile Performance [...]

Q3 Share Price Performance in 2017 – Part 1

By | November 8th, 2017|Analysis, Blog, Capital Markets|

Very High Volatility and Mixed Performance The key statistic from [...]

Q2 Share Price Performance in 2017 – Part 3

By | July 19th, 2017|Analysis, Blog, Capital Markets|

In the final instalment of this analysis, I will comment [...]

Q2 Share Price Performance in 2017 – Part 2

By | July 12th, 2017|Analysis, Blog, Capital Markets|

          Overall, Tier 1 Canadian Healthcare [...]

Q1 Share Price Performance in 2017 – Part 3

By | April 7th, 2017|Analysis, Blog, Capital Markets|

Tier 2 Canadian Healthcare Companies – nicely positive with moderate [...]

Q1 Share Price Performance in 2017 – Part 2

By | April 6th, 2017|Analysis, Blog, Capital Markets|

Tier 1 Canadian Healthcare Companies – positive based on both [...]